Thrombomodulin (THBD) gene variants and thrombotic risk in a population‐based cohort study

Background The protein C anticoagulant system plays a key role in maintaining the hemostatic balance. Although several studies have identified thrombomodulin gene (THBD) variants among venous thromboembolism (VTE) patients, the role of THBD in relation to VTE in humans remains to be clarified. Objec...

Full description

Saved in:
Bibliographic Details
Published inJournal of thrombosis and haemostasis Vol. 20; no. 4; pp. 929 - 935
Main Authors Manderstedt, Eric, Halldén, Christer, Lind‐Halldén, Christina, Elf, Johan, Svensson, Peter J., Engström, Gunnar, Melander, Olle, Baras, Aris, Lotta, Luca A., Zöller, Bengt
Format Journal Article
LanguageEnglish
Published England Elsevier Limited 01.04.2022
Subjects
Online AccessGet full text
ISSN1538-7933
1538-7836
1538-7836
DOI10.1111/jth.15630

Cover

Abstract Background The protein C anticoagulant system plays a key role in maintaining the hemostatic balance. Although several studies have identified thrombomodulin gene (THBD) variants among venous thromboembolism (VTE) patients, the role of THBD in relation to VTE in humans remains to be clarified. Objectives This study aimed to determine the thrombotic risk of rare and common THBD variants in a large population‐based cohort of middle‐aged and older adults. Patients/Methods The exome sequence of THBD was analyzed for qualifying variants in 28,794 subjects (born 1923–1950, 60% women), who participated in the Malmö Diet and Cancer study (1991–1996). Patients were followed from baseline until the first event of VTE, death, or 2018. Qualifying variants were defined as loss‐of‐function or non‐benign (PolyPhen‐2) missense variants with minor allele frequency <0.1%. Results The single common coding variant rs1042579 was not associated with incident VTE. Sixteen rare variants were classified as qualifying and included in collapsing analysis. Seven individuals with VTE compared to 24 individuals without VTE carried one qualifying variant. Cox multivariate regression analysis adjusted for age, sex, body mass index, systolic blood pressure, smoking and alcohol consumption, rs6025, rs1799963, and the top two eigenvectors from a principal components analysis showed a hazard ratio of 3.0 (95% confidence interval 1.4–6.3) for the rare qualifying variants. The distributions of qualifying variants in THBD showed a difference for individuals with and without incident VTE indicating a possible position effect. Conclusions Rare qualifying THBD variants were associated with VTE, suggesting that rare variants in THBD contribute to development of VTE.
AbstractList The protein C anticoagulant system plays a key role in maintaining the hemostatic balance. Although several studies have identified thrombomodulin gene (THBD) variants among venous thromboembolism (VTE) patients, the role of THBD in relation to VTE in humans remains to be clarified. This study aimed to determine the thrombotic risk of rare and common THBD variants in a large population-based cohort of middle-aged and older adults. The exome sequence of THBD was analyzed for qualifying variants in 28,794 subjects (born 1923-1950, 60% women), who participated in the Malmö Diet and Cancer study (1991-1996). Patients were followed from baseline until the first event of VTE, death, or 2018. Qualifying variants were defined as loss-of-function or non-benign (PolyPhen-2) missense variants with minor allele frequency <0.1%. The single common coding variant rs1042579 was not associated with incident VTE. Sixteen rare variants were classified as qualifying and included in collapsing analysis. Seven individuals with VTE compared to 24 individuals without VTE carried one qualifying variant. Cox multivariate regression analysis adjusted for age, sex, body mass index, systolic blood pressure, smoking and alcohol consumption, rs6025, rs1799963, and the top two eigenvectors from a principal components analysis showed a hazard ratio of 3.0 (95% confidence interval 1.4-6.3) for the rare qualifying variants. The distributions of qualifying variants in THBD showed a difference for individuals with and without incident VTE indicating a possible position effect. Rare qualifying THBD variants were associated with VTE, suggesting that rare variants in THBD contribute to development of VTE.
BackgroundThe protein C anticoagulant system plays a key role in maintaining the hemostatic balance. Although several studies have identified thrombomodulin gene (THBD) variants among venous thromboembolism (VTE) patients, the role of THBD in relation to VTE in humans remains to be clarified.ObjectivesThis study aimed to determine the thrombotic risk of rare and common THBD variants in a large population‐based cohort of middle‐aged and older adults.Patients/MethodsThe exome sequence of THBD was analyzed for qualifying variants in 28,794 subjects (born 1923–1950, 60% women), who participated in the Malmö Diet and Cancer study (1991–1996). Patients were followed from baseline until the first event of VTE, death, or 2018. Qualifying variants were defined as loss‐of‐function or non‐benign (PolyPhen‐2) missense variants with minor allele frequency <0.1%.ResultsThe single common coding variant rs1042579 was not associated with incident VTE. Sixteen rare variants were classified as qualifying and included in collapsing analysis. Seven individuals with VTE compared to 24 individuals without VTE carried one qualifying variant. Cox multivariate regression analysis adjusted for age, sex, body mass index, systolic blood pressure, smoking and alcohol consumption, rs6025, rs1799963, and the top two eigenvectors from a principal components analysis showed a hazard ratio of 3.0 (95% confidence interval 1.4–6.3) for the rare qualifying variants. The distributions of qualifying variants in THBD showed a difference for individuals with and without incident VTE indicating a possible position effect.ConclusionsRare qualifying THBD variants were associated with VTE, suggesting that rare variants in THBD contribute to development of VTE.
Background: The protein C anticoagulant system plays a key role in maintaining the hemostatic balance. Although several studies have identified thrombomodulin gene (THBD) variants among venous thromboembolism (VTE) patients, the role of THBD in relation to VTE in humans remains to be clarified. Objectives: This study aimed to determine the thrombotic risk of rare and common THBD variants in a large population-based cohort of middle-aged and older adults. Patients/Methods: The exome sequence of THBD was analyzed for qualifying variants in 28,794 subjects (born 1923–1950, 60% women), who participated in the Malmö Diet and Cancer study (1991–1996). Patients were followed from baseline until the first event of VTE, death, or 2018. Qualifying variants were defined as loss-of-function or non-benign (PolyPhen-2) missense variants with minor allele frequency <0.1%. Results: The single common coding variant rs1042579 was not associated with incident VTE. Sixteen rare variants were classified as qualifying and includedin collapsing analysis. Seven individuals with VTE compared to 24 individuals without VTE carried one qualifying variant. Cox multivariate regression analysis adjusted for age, sex, body mass index, systolic blood pressure, smoking and alcohol consumption, rs6025, rs1799963, and the top two eigenvectors from a principal components analysis showed a hazard ratio of 3.0 (95% confidence interval 1.4–6.3) for the rare qualifying variants. The distributions of qualifying variants in THBD showed a difference for individuals with and without incident VTE indicating a possible position effect. Conclusions: Rare qualifying THBD variants were associated with VTE, suggesting that rare variants in THBD contribute to development of VTE.
Background The protein C anticoagulant system plays a key role in maintaining the hemostatic balance. Although several studies have identified thrombomodulin gene (THBD) variants among venous thromboembolism (VTE) patients, the role of THBD in relation to VTE in humans remains to be clarified. Objectives This study aimed to determine the thrombotic risk of rare and common THBD variants in a large population‐based cohort of middle‐aged and older adults. Patients/Methods The exome sequence of THBD was analyzed for qualifying variants in 28,794 subjects (born 1923–1950, 60% women), who participated in the Malmö Diet and Cancer study (1991–1996). Patients were followed from baseline until the first event of VTE, death, or 2018. Qualifying variants were defined as loss‐of‐function or non‐benign (PolyPhen‐2) missense variants with minor allele frequency <0.1%. Results The single common coding variant rs1042579 was not associated with incident VTE. Sixteen rare variants were classified as qualifying and included in collapsing analysis. Seven individuals with VTE compared to 24 individuals without VTE carried one qualifying variant. Cox multivariate regression analysis adjusted for age, sex, body mass index, systolic blood pressure, smoking and alcohol consumption, rs6025, rs1799963, and the top two eigenvectors from a principal components analysis showed a hazard ratio of 3.0 (95% confidence interval 1.4–6.3) for the rare qualifying variants. The distributions of qualifying variants in THBD showed a difference for individuals with and without incident VTE indicating a possible position effect. Conclusions Rare qualifying THBD variants were associated with VTE, suggesting that rare variants in THBD contribute to development of VTE.
Background: The protein C anticoagulant system plays a key role in maintaining the hemostatic balance. Although several studies have identified thrombomodulin gene (THBD) variants among venous thromboembolism (VTE) patients, the role of THBD in relation to VTE in humans remains to be clarified. Objectives: This study aimed to determine the thrombotic risk of rare and common THBD variants in a large population-based cohort of middle-aged and older adults. Patients/Methods: The exome sequence of THBD was analyzed for qualifying variants in 28,794 subjects (born 1923–1950, 60% women), who participated in the Malmö Diet and Cancer study (1991–1996). Patients were followed from baseline until the first event of VTE, death, or 2018. Qualifying variants were defined as loss-of-function or non-benign (PolyPhen-2) missense variants with minor allele frequency <0.1%. Results: The single common coding variant rs1042579 was not associated with incident VTE. Sixteen rare variants were classified as qualifying and included in collapsing analysis. Seven individuals with VTE compared to 24 individuals without VTE carried one qualifying variant. Cox multivariate regression analysis adjusted for age, sex, body mass index, systolic blood pressure, smoking and alcohol consumption, rs6025, rs1799963, and the top two eigenvectors from a principal components analysis showed a hazard ratio of 3.0 (95% confidence interval 1.4–6.3) for the rare qualifying variants. The distributions of qualifying variants in THBD showed a difference for individuals with and without incident VTE indicating a possible position effect. Conclusions: Rare qualifying THBD variants were associated with VTE, suggesting that rare variants in THBD contribute to development of VTE.
The protein C anticoagulant system plays a key role in maintaining the hemostatic balance. Although several studies have identified thrombomodulin gene (THBD) variants among venous thromboembolism (VTE) patients, the role of THBD in relation to VTE in humans remains to be clarified.BACKGROUNDThe protein C anticoagulant system plays a key role in maintaining the hemostatic balance. Although several studies have identified thrombomodulin gene (THBD) variants among venous thromboembolism (VTE) patients, the role of THBD in relation to VTE in humans remains to be clarified.This study aimed to determine the thrombotic risk of rare and common THBD variants in a large population-based cohort of middle-aged and older adults.OBJECTIVESThis study aimed to determine the thrombotic risk of rare and common THBD variants in a large population-based cohort of middle-aged and older adults.The exome sequence of THBD was analyzed for qualifying variants in 28,794 subjects (born 1923-1950, 60% women), who participated in the Malmö Diet and Cancer study (1991-1996). Patients were followed from baseline until the first event of VTE, death, or 2018. Qualifying variants were defined as loss-of-function or non-benign (PolyPhen-2) missense variants with minor allele frequency <0.1%.PATIENTS/METHODSThe exome sequence of THBD was analyzed for qualifying variants in 28,794 subjects (born 1923-1950, 60% women), who participated in the Malmö Diet and Cancer study (1991-1996). Patients were followed from baseline until the first event of VTE, death, or 2018. Qualifying variants were defined as loss-of-function or non-benign (PolyPhen-2) missense variants with minor allele frequency <0.1%.The single common coding variant rs1042579 was not associated with incident VTE. Sixteen rare variants were classified as qualifying and included in collapsing analysis. Seven individuals with VTE compared to 24 individuals without VTE carried one qualifying variant. Cox multivariate regression analysis adjusted for age, sex, body mass index, systolic blood pressure, smoking and alcohol consumption, rs6025, rs1799963, and the top two eigenvectors from a principal components analysis showed a hazard ratio of 3.0 (95% confidence interval 1.4-6.3) for the rare qualifying variants. The distributions of qualifying variants in THBD showed a difference for individuals with and without incident VTE indicating a possible position effect.RESULTSThe single common coding variant rs1042579 was not associated with incident VTE. Sixteen rare variants were classified as qualifying and included in collapsing analysis. Seven individuals with VTE compared to 24 individuals without VTE carried one qualifying variant. Cox multivariate regression analysis adjusted for age, sex, body mass index, systolic blood pressure, smoking and alcohol consumption, rs6025, rs1799963, and the top two eigenvectors from a principal components analysis showed a hazard ratio of 3.0 (95% confidence interval 1.4-6.3) for the rare qualifying variants. The distributions of qualifying variants in THBD showed a difference for individuals with and without incident VTE indicating a possible position effect.Rare qualifying THBD variants were associated with VTE, suggesting that rare variants in THBD contribute to development of VTE.CONCLUSIONSRare qualifying THBD variants were associated with VTE, suggesting that rare variants in THBD contribute to development of VTE.
Author Lind‐Halldén, Christina
Lotta, Luca A.
Manderstedt, Eric
Halldén, Christer
Engström, Gunnar
Zöller, Bengt
Elf, Johan
Svensson, Peter J.
Baras, Aris
Melander, Olle
AuthorAffiliation Regeneron Genetics Center, Tarrytown, New York, USA
AuthorAffiliation_xml – name: Regeneron Genetics Center, Tarrytown, New York, USA
Author_xml – sequence: 1
  givenname: Eric
  orcidid: 0000-0002-8984-9697
  surname: Manderstedt
  fullname: Manderstedt, Eric
  organization: Kristianstad University
– sequence: 2
  givenname: Christer
  surname: Halldén
  fullname: Halldén, Christer
  organization: Kristianstad University
– sequence: 3
  givenname: Christina
  surname: Lind‐Halldén
  fullname: Lind‐Halldén, Christina
  organization: Kristianstad University
– sequence: 4
  givenname: Johan
  surname: Elf
  fullname: Elf, Johan
  organization: Lund University
– sequence: 5
  givenname: Peter J.
  surname: Svensson
  fullname: Svensson, Peter J.
  organization: Lund University
– sequence: 6
  givenname: Gunnar
  surname: Engström
  fullname: Engström, Gunnar
  organization: Lund University
– sequence: 7
  givenname: Olle
  surname: Melander
  fullname: Melander, Olle
  organization: Lund University
– sequence: 8
  givenname: Aris
  surname: Baras
  fullname: Baras, Aris
  organization: Regeneron Genetics Center
– sequence: 9
  givenname: Luca A.
  surname: Lotta
  fullname: Lotta, Luca A.
  organization: Regeneron Genetics Center
– sequence: 10
  givenname: Bengt
  orcidid: 0000-0002-8250-5613
  surname: Zöller
  fullname: Zöller, Bengt
  email: bengt.zoller@med.lu.se
  organization: Lund University and Region Skåne
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34970867$$D View this record in MEDLINE/PubMed
BookMark eNp1kstu1DAYhSNURC-w4AVQJDbtYlo7jhN7CeUyoEpshh3SL1_-dDxN4mAnVLPjEXhGngTPDYmKemMvvv-cY_ucZke97zHLXlJySdO6Wo3LS8orRp5kJ5QzMasFq44OZ8nYcXYa44oQKnlBnmXHrJQ1EVV9kn1bLIPvtO-8nVrX5-eL-dt3F_kt9pj_UMGpfoy56m0-7rjRmTy4eJcnVuWDH6ZWjc73v3_-0iqizY1f-jDmcZzs-nn2tFFtxBf7_Sz7-uH94no-u_ny8dP1m5uZ4XVJZpRRXtuqEYKjFZobLJCqyhhhDRJjGmkKo2WlGiOLshJSpOs1jeRCUsMJYWfZ7U433uMwaRiC61RYg1cOAkZUwSyHlEq1sLwLEBGU7VwPiW2d2eaPwAoUstQFFFUhodRVCVqVEmqllNQF5aTgyUk96rR3OBhCO22c_vHgtuZaNxIM1g2UTW1AoCGgscIGLWGM0-RxvvMYgv8-YRyhc9Fg26oe_RRTPsollSlRQl8_QFd-Cn1660SV6Ye5lBvBV3tq0h3av6EPLUjA1Q4wwccYsAHjxm3kMSjXAiWw6RmknsG2Z2ni4sHEQfR_7F793rW4fhyEz4v5buIPms3l8A
CitedBy_id crossref_primary_10_1016_j_rpth_2025_102692
crossref_primary_10_1136_bmjopen_2023_072934
crossref_primary_10_1161_JAHA_122_027502
crossref_primary_10_3389_fcvm_2022_1066065
crossref_primary_10_1002_rth2_12842
crossref_primary_10_1016_j_jtha_2023_12_004
crossref_primary_10_1016_j_psj_2023_103416
crossref_primary_10_1016_j_envpol_2023_121841
crossref_primary_10_1182_blood_2023022996
crossref_primary_10_1016_j_tru_2025_100198
crossref_primary_10_1016_j_jtemb_2024_127413
crossref_primary_10_1016_j_tru_2023_100145
crossref_primary_10_3389_fcvm_2023_1294218
crossref_primary_10_1161_ATVBAHA_124_322116
crossref_primary_10_3389_fphar_2024_1402758
crossref_primary_10_1016_j_tru_2024_100190
crossref_primary_10_1016_j_jtha_2023_11_024
crossref_primary_10_1186_s40164_024_00555_x
crossref_primary_10_3389_fcvm_2022_1059543
crossref_primary_10_1007_s11239_024_02987_y
Cites_doi 10.1186/1471-2458-11-450
10.1016/j.ajhg.2020.06.009
10.1182/blood.2019000435
10.1111/j.1538-7836.2007.02857.x
10.1016/j.thromres.2013.12.013
10.1182/blood.V99.10.3646
10.1182/blood-2017-12-768994
10.1172/JCI200113077
10.1021/bi00388a025
10.1016/j.humimm.2019.10.002
10.1073/pnas.78.4.2249
10.1182/blood-2015-09-668525
10.1001/archinte.1997.00440360079008
10.1055/s-0038-1657559
10.1055/s-0038-1657708
10.1182/blood.V85.2.330.330
10.1111/j.1538-7836.2005.01187.x
10.1093/nar/gkq603
10.1038/s41588-019-0519-3
10.1161/ATVBAHA.113.301360
10.1055/s-0038-1648181
10.1378/chest.124.3_suppl.26S
10.1007/s11239-015-1328-x
10.1161/CIRCGEN.121.003449
10.1016/j.thromres.2009.04.022
10.1172/JCI2006
10.1080/17474086.2020.1804354
10.1046/j.1365-2141.2002.03644.x
10.1016/j.thromres.2005.12.012
10.1073/pnas.92.3.850
ContentType Journal Article
Copyright 2022 The Authors. published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis
2022 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis.
2022. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2022 The Authors. published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis
– notice: 2022 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis.
– notice: 2022. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
CorporateAuthor Regeneron Genetics Center
Kardiovaskulär forskning - epidemiologi
Institutionen för translationell medicin
Department of Translational Medicine
MultiPark: Multidisciplinary research focused on Parkinson's disease
Lunds universitet
Profile areas and other strong research environments
Department of Clinical Sciences, Malmö
Lund University
Family medicine, cardiovascular medicine and genetics
Klinisk koagulationsmedicin, Malmö
Kardiovaskulär forskning - hypertoni
Strategiska forskningsområden (SFO)
EpiHealth: Epidemiology for Health
Allmänmedicin, kardiovaskulär medicin och genetik
EXODIAB: Excellence of Diabetes Research in Sweden
Faculty of Medicine
Strategic research areas (SRA)
Medicinska fakulteten
Clinical Coagulation, Malmö
Profilområden och andra starka forskningsmiljöer
Cardiovascular Research - Epidemiology
Institutionen för kliniska vetenskaper, Malmö
Cardiovascular Research - Hypertension
Fakulteten för naturvetenskap
Kristianstad University
Faculty of Natural Science
Högskolan Kristianstad
CorporateAuthor_xml – name: Regeneron Genetics Center
– name: Faculty of Medicine
– name: Medicinska fakulteten
– name: Strategiska forskningsområden (SFO)
– name: Kardiovaskulär forskning - epidemiologi
– name: Cardiovascular Research - Hypertension
– name: Kardiovaskulär forskning - hypertoni
– name: EpiHealth: Epidemiology for Health
– name: Institutionen för kliniska vetenskaper, Malmö
– name: Strategic research areas (SRA)
– name: Lunds universitet
– name: Klinisk koagulationsmedicin, Malmö
– name: Clinical Coagulation, Malmö
– name: Allmänmedicin, kardiovaskulär medicin och genetik
– name: Profilområden och andra starka forskningsmiljöer
– name: Lund University
– name: EXODIAB: Excellence of Diabetes Research in Sweden
– name: Department of Translational Medicine
– name: Profile areas and other strong research environments
– name: Cardiovascular Research - Epidemiology
– name: MultiPark: Multidisciplinary research focused on Parkinson's disease
– name: Institutionen för translationell medicin
– name: Department of Clinical Sciences, Malmö
– name: Family medicine, cardiovascular medicine and genetics
– name: Högskolan Kristianstad
– name: Fakulteten för naturvetenskap
– name: Kristianstad University
– name: Faculty of Natural Science
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
K9.
7X8
ADTPV
AGCHP
AOWAS
D8T
D95
ZZAVC
ALKSL
D96
DOI 10.1111/jth.15630
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
SwePub
SWEPUB Lunds universitet full text
SwePub Articles
SWEPUB Freely available online
SWEPUB Lunds universitet
SwePub Articles full text
SWEPUB Högskolan Kristianstad full text
SWEPUB Högskolan Kristianstad
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE
AIDS and Cancer Research Abstracts



MEDLINE - Academic
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1538-7836
EndPage 935
ExternalDocumentID oai_researchportal_hkr_se_admin_publications_32e894b2_2629_4b64_ba49_7aaa9b215025
oai_portal_research_lu_se_publications_5d75bbf9_ce7f_4f7c_8ec0_be6efed03351
34970867
10_1111_jth_15630
JTH15630
Genre shortCommunication
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Vetenskapsrådet
– fundername: Sparbanken Skåne
– fundername: ALF‐funding from Region Skåne
GroupedDBID ---
05W
1OC
24P
29L
2WC
31~
33P
36B
3SF
4.4
52U
52V
53G
5GY
5VS
66C
8-0
8-1
A00
AAESR
AAEVG
AAHHS
AALRI
AAONW
AASGY
AAXRX
AAXUO
AAZKR
ABCUV
ABDBF
ABJNI
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACMXC
ACPOU
ACPRK
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADVLN
ADXAS
ADZMN
AEEZP
AEIMD
AENEX
AEQDE
AFBPY
AFEBI
AFGKR
AFJKZ
AFPWT
AFZJQ
AHMBA
AIACR
AITUG
AIURR
AIWBW
AJAOE
AJBDE
AKRWK
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMRAJ
AMYDB
ATUGU
AZBYB
AZVAB
BAWUL
BHBCM
BMXJE
BOGZA
BRXPI
C45
CAG
COF
CS3
DCZOG
DIK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EAD
EAP
EBS
EJD
EMB
EMK
ESX
F5P
FDB
FIJ
FUBAC
G-S
GODZA
HZ~
IHE
IPNFZ
IX1
KBYEO
LATKE
LEEKS
LH4
LITHE
LOXES
LUTES
LW6
LYRES
M41
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
MY~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P4E
PQQKQ
ROL
SUPJJ
SV3
TEORI
TR2
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WVDHM
WYJ
ZZTAW
AAYWO
AAYXX
ACVFH
ADCNI
AEUPX
AFPUW
AGCQF
AIGII
AKBMS
AKYEP
APXCP
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
EFKBS
H94
K9.
7X8
ADTPV
AGCHP
AOWAS
D8T
D95
ZZAVC
ALKSL
D96
ID FETCH-LOGICAL-c5740-13157d6f885ed8b5ce2e1a6cc8dce0ccf9c2cb96afc9246898836ff95891c5003
IEDL.DBID DR2
ISSN 1538-7933
1538-7836
IngestDate Fri Sep 12 03:11:50 EDT 2025
Sun Sep 21 03:12:35 EDT 2025
Sat Sep 27 23:59:36 EDT 2025
Wed Aug 13 05:46:56 EDT 2025
Thu Apr 03 06:57:56 EDT 2025
Thu Apr 24 23:02:57 EDT 2025
Tue Jul 01 00:27:27 EDT 2025
Wed Jan 22 16:25:38 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords THBD
epidemiology
genetics
venous thromboembolism
thrombomodulin
Language English
License Attribution-NonCommercial
2022 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5740-13157d6f885ed8b5ce2e1a6cc8dce0ccf9c2cb96afc9246898836ff95891c5003
Notes Manuscript handled by: Roger Preston
Final decision: Roger Preston, 27 December 2021
A list of the Regeneron Genetics Center is provided in at the end of the article.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-8250-5613
0000-0002-8984-9697
OpenAccessLink https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjth.15630
PMID 34970867
PQID 2640865991
PQPubID 1086376
PageCount 7
ParticipantIDs swepub_primary_oai_researchportal_hkr_se_admin_publications_32e894b2_2629_4b64_ba49_7aaa9b215025
swepub_primary_oai_portal_research_lu_se_publications_5d75bbf9_ce7f_4f7c_8ec0_be6efed03351
proquest_miscellaneous_2615919215
proquest_journals_2640865991
pubmed_primary_34970867
crossref_citationtrail_10_1111_jth_15630
crossref_primary_10_1111_jth_15630
wiley_primary_10_1111_jth_15630_JTH15630
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate April 2022
PublicationDateYYYYMMDD 2022-04-01
PublicationDate_xml – month: 04
  year: 2022
  text: April 2022
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle Journal of thrombosis and haemostasis
PublicationTitleAlternate J Thromb Haemost
PublicationYear 2022
Publisher Elsevier Limited
Publisher_xml – name: Elsevier Limited
References 1997; 157
2010; 38
1995; 92
2019; 51
2002; 99
2002; 118
2011; 11
2020; 107
2020; 13
2016; 127
2008; 6
2001; 108
2014; 133
2021; 14
1995; 85
2019; 80
2018; 132
2007; 119
2013; 33
1991; 65
1997; 78
2016; 42
2009; 124
2005; 3
2003; 124
1998; 101
2019; 134
1981; 78
1987; 26
Hansson (10.1111/jth.15630_bb0155) 1997; 157
Healy (10.1111/jth.15630_bb0145) 1995; 92
Faioni (10.1111/jth.15630_bb0090) 2002; 118
Ahmad (10.1111/jth.15630_bb0095) 2016; 42
Esmon (10.1111/jth.15630_bb0010) 1981; 78
Isma (10.1111/jth.15630_bb0150) 2009; 124
Esmon (10.1111/jth.15630_bb0015) 2003; 124
Wen (10.1111/jth.15630_bb0025) 1987; 26
Manderstedt (10.1111/jth.15630_bb0115) 2021; 14
Lindström (10.1111/jth.15630_bb0060) 2019; 134
Ohlin (10.1111/jth.15630_bb0070) 1997; 78
Norlund (10.1111/jth.15630_bb0075) 1997; 78
Heit (10.1111/jth.15630_bb0105) 2005; 3
Navarro (10.1111/jth.15630_bb0080) 2013; 33
Kunz (10.1111/jth.15630_bb0040) 2002; 99
van der Velden (10.1111/jth.15630_bb0085) 1991; 65
Zöller (10.1111/jth.15630_bb0110) 2014; 133
Wang (10.1111/jth.15630_bb0135) 2010; 38
Rosengren (10.1111/jth.15630_bb0120) 2008; 6
Loghmani (10.1111/jth.15630_bb0020) 2018; 132
Ludvigsson (10.1111/jth.15630_bb0125) 2011; 11
Sugiyama (10.1111/jth.15630_bb0100) 2007; 119
Zöller (10.1111/jth.15630_bb0045) 2020; 13
Klarin (10.1111/jth.15630_bb0065) 2019; 51
Isermann (10.1111/jth.15630_bb0035) 2001; 108
Williams (10.1111/jth.15630_bb0130) 2019; 80
Kim (10.1111/jth.15630_bb0140) 2020; 107
Weiler‐Guettler (10.1111/jth.15630_bb0030) 1998; 101
Ohlin (10.1111/jth.15630_bb0050) 1995; 85
Hernandez (10.1111/jth.15630_bb0055) 2016; 127
References_xml – volume: 6
  start-page: 558
  year: 2008
  end-page: 564
  article-title: Psychosocial factors and venous thromboembolism: a long‐term follow‐up study of Swedish men
  publication-title: J Thromb Haemost
– volume: 26
  start-page: 4350
  year: 1987
  end-page: 4357
  article-title: Human thrombomodulin: complete cDNA sequence and chromosome localization of the gene
  publication-title: Biochemistry
– volume: 65
  start-page: 511
  year: 1991
  end-page: 513
  article-title: A frequent thrombomodulin amino acid dimorphism is not associated with thrombophilia
  publication-title: Thromb Haemost
– volume: 11
  start-page: 450
  year: 2011
  article-title: External review and validation of the Swedish national inpatient register
  publication-title: BMC Public Health
– volume: 14
  issue: 5
  year: 2021
  article-title: Regeneron Genetics Center. Thrombotic risk determined by STAB 2 Variants in a Population‐Based Cohort Study
  publication-title: Circ Genom Precis Med
– volume: 78
  start-page: 396
  year: 1997
  end-page: 400
  article-title: Thrombomodulin gene variations and thromboembolic disease
  publication-title: Thromb Haemost
– volume: 38
  start-page: e164
  year: 2010
  article-title: ANNOVAR: functional annotation of genetic variants from high‐throughput sequencing data
  publication-title: Nucleic Acids Res
– volume: 124
  start-page: 26S
  issue: 3 Suppl
  year: 2003
  end-page: 32S
  article-title: The protein C pathway
  publication-title: Chest
– volume: 132
  start-page: 148
  year: 2018
  end-page: 158
  article-title: Exploring traditional and nontraditional roles for thrombomodulin
  publication-title: Blood
– volume: 101
  start-page: 1983
  year: 1998
  end-page: 1991
  article-title: A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state
  publication-title: J Clin Invest
– volume: 99
  start-page: 3646
  issue: 10
  year: 2002
  end-page: 3653
  article-title: Naturally occurring mutations in the thrombomodulin gene leading to impaired expression and function
  publication-title: Blood
– volume: 33
  start-page: 1435
  year: 2013
  end-page: 1440
  article-title: Association of the thrombomodulin gene c.1418C>T polymorphism with thrombomodulin levels and with venous thrombosis risk
  publication-title: Arterioscler Thromb Vasc Biol
– volume: 133
  start-page: 334
  year: 2014
  end-page: 339
  article-title: Red cell distribution width and risk for venous thromboembolism: a population‐based cohort study
  publication-title: Thromb Res
– volume: 119
  start-page: 35
  year: 2007
  end-page: 43
  article-title: Haplotype of thrombomodulin gene associated with plasma thrombomodulin level and deep vein thrombosis in the Japanese population
  publication-title: Thromb Res
– volume: 127
  start-page: 1923
  year: 2016
  end-page: 1929
  article-title: Novel genetic predictors of venous thromboembolism risk in African Americans
  publication-title: Blood
– volume: 107
  start-page: 251
  issue: 2
  year: 2020
  end-page: 264
  article-title: Characterization of Exome Variants and Their Metabolic Impact in 6,716 American Indians from the Southwest US
  publication-title: Am J Hum Genet
– volume: 108
  start-page: 537
  year: 2001
  end-page: 546
  article-title: Endothelium specific loss of murine thrombomodulin disrupts the protein C anticoagulant pathway and causes juvenile‐onset thrombosis
  publication-title: J Clin Invest
– volume: 134
  start-page: 1645
  year: 2019
  end-page: 1657
  article-title: Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism
  publication-title: Blood
– volume: 157
  start-page: 1665
  year: 1997
  end-page: 1670
  article-title: Deep vein thrombosis and pulmonary embolism in the general population. ‘The Study of Men Born in 1913'
  publication-title: Arch Intern Med
– volume: 78
  start-page: 1164
  year: 1997
  end-page: 1166
  article-title: A novel thrombomodulin gene mutation in a patient suffering from sagittal sinus thrombosis
  publication-title: Thromb Haemost
– volume: 124
  start-page: 663
  year: 2009
  end-page: 666
  article-title: Prospective analysis of risk factors and distribution of venous thromboembolism in the population‐based Malmö Thrombophilia Study (MATS)
  publication-title: Thromb Res
– volume: 13
  start-page: 971
  year: 2020
  end-page: 981
  article-title: Genetic risk factors for venous thromboembolism
  publication-title: Expert Rev Hematol
– volume: 85
  start-page: 330
  year: 1995
  end-page: 336
  article-title: The first mutation identified in the thrombomodulin gene in a 45‐year‐old man presenting with thromboembolic disease
  publication-title: Blood
– volume: 78
  start-page: 2249
  year: 1981
  end-page: 2252
  article-title: Identification of an endothelial cell cofactor for thrombin‐catalyzed activation of protein C
  publication-title: Proc Natl Acad Sci USA
– volume: 42
  start-page: 135
  year: 2016
  end-page: 141
  article-title: Thrombomodulin gene c.1418C>T polymorphism and risk of recurrent venous thromboembolism
  publication-title: J Thromb Thrombolysis
– volume: 80
  start-page: 955
  year: 2019
  end-page: 965
  article-title: Next generation sequencing and the classical HLA loci in full heritage Pima Indians of Arizona: defining the core HLA variation for North American Paleo‐Indians
  publication-title: Hum Immunol
– volume: 118
  start-page: 595
  year: 2002
  end-page: 599
  article-title: Mutations in the thrombomodulin gene are rare in patients with severe thrombophilia
  publication-title: Br J Haematol
– volume: 3
  start-page: 710
  year: 2005
  end-page: 717
  article-title: Thrombomodulin gene polymorphisms or haplotypes as potential risk factors for venous thromboembolism: a population‐based case‐control study
  publication-title: J Thromb Haemost
– volume: 51
  start-page: 1574
  year: 2019
  end-page: 1579
  article-title: Genome‐wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease
  publication-title: Nat Genet
– volume: 92
  start-page: 850
  year: 1995
  end-page: 854
  article-title: Absence of the blood‐clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system
  publication-title: Proc Natl Acad Sci USA
– volume: 11
  start-page: 450
  year: 2011
  ident: 10.1111/jth.15630_bb0125
  article-title: External review and validation of the Swedish national inpatient register
  publication-title: BMC Public Health
  doi: 10.1186/1471-2458-11-450
– volume: 107
  start-page: 251
  issue: 2
  year: 2020
  ident: 10.1111/jth.15630_bb0140
  article-title: Characterization of Exome Variants and Their Metabolic Impact in 6,716 American Indians from the Southwest US
  publication-title: Am J Hum Genet
  doi: 10.1016/j.ajhg.2020.06.009
– volume: 134
  start-page: 1645
  year: 2019
  ident: 10.1111/jth.15630_bb0060
  article-title: Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism
  publication-title: Blood
  doi: 10.1182/blood.2019000435
– volume: 6
  start-page: 558
  year: 2008
  ident: 10.1111/jth.15630_bb0120
  article-title: Psychosocial factors and venous thromboembolism: a long‐term follow‐up study of Swedish men
  publication-title: J Thromb Haemost
  doi: 10.1111/j.1538-7836.2007.02857.x
– volume: 133
  start-page: 334
  year: 2014
  ident: 10.1111/jth.15630_bb0110
  article-title: Red cell distribution width and risk for venous thromboembolism: a population‐based cohort study
  publication-title: Thromb Res
  doi: 10.1016/j.thromres.2013.12.013
– volume: 99
  start-page: 3646
  issue: 10
  year: 2002
  ident: 10.1111/jth.15630_bb0040
  article-title: Naturally occurring mutations in the thrombomodulin gene leading to impaired expression and function
  publication-title: Blood
  doi: 10.1182/blood.V99.10.3646
– volume: 132
  start-page: 148
  year: 2018
  ident: 10.1111/jth.15630_bb0020
  article-title: Exploring traditional and nontraditional roles for thrombomodulin
  publication-title: Blood
  doi: 10.1182/blood-2017-12-768994
– volume: 108
  start-page: 537
  year: 2001
  ident: 10.1111/jth.15630_bb0035
  article-title: Endothelium specific loss of murine thrombomodulin disrupts the protein C anticoagulant pathway and causes juvenile‐onset thrombosis
  publication-title: J Clin Invest
  doi: 10.1172/JCI200113077
– volume: 26
  start-page: 4350
  year: 1987
  ident: 10.1111/jth.15630_bb0025
  article-title: Human thrombomodulin: complete cDNA sequence and chromosome localization of the gene
  publication-title: Biochemistry
  doi: 10.1021/bi00388a025
– volume: 80
  start-page: 955
  year: 2019
  ident: 10.1111/jth.15630_bb0130
  article-title: Next generation sequencing and the classical HLA loci in full heritage Pima Indians of Arizona: defining the core HLA variation for North American Paleo‐Indians
  publication-title: Hum Immunol
  doi: 10.1016/j.humimm.2019.10.002
– volume: 78
  start-page: 2249
  year: 1981
  ident: 10.1111/jth.15630_bb0010
  article-title: Identification of an endothelial cell cofactor for thrombin‐catalyzed activation of protein C
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.78.4.2249
– volume: 127
  start-page: 1923
  year: 2016
  ident: 10.1111/jth.15630_bb0055
  article-title: Novel genetic predictors of venous thromboembolism risk in African Americans
  publication-title: Blood
  doi: 10.1182/blood-2015-09-668525
– volume: 157
  start-page: 1665
  year: 1997
  ident: 10.1111/jth.15630_bb0155
  article-title: Deep vein thrombosis and pulmonary embolism in the general population. ‘The Study of Men Born in 1913'
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.1997.00440360079008
– volume: 78
  start-page: 396
  year: 1997
  ident: 10.1111/jth.15630_bb0070
  article-title: Thrombomodulin gene variations and thromboembolic disease
  publication-title: Thromb Haemost
  doi: 10.1055/s-0038-1657559
– volume: 78
  start-page: 1164
  year: 1997
  ident: 10.1111/jth.15630_bb0075
  article-title: A novel thrombomodulin gene mutation in a patient suffering from sagittal sinus thrombosis
  publication-title: Thromb Haemost
  doi: 10.1055/s-0038-1657708
– volume: 85
  start-page: 330
  year: 1995
  ident: 10.1111/jth.15630_bb0050
  article-title: The first mutation identified in the thrombomodulin gene in a 45‐year‐old man presenting with thromboembolic disease
  publication-title: Blood
  doi: 10.1182/blood.V85.2.330.330
– volume: 3
  start-page: 710
  year: 2005
  ident: 10.1111/jth.15630_bb0105
  article-title: Thrombomodulin gene polymorphisms or haplotypes as potential risk factors for venous thromboembolism: a population‐based case‐control study
  publication-title: J Thromb Haemost
  doi: 10.1111/j.1538-7836.2005.01187.x
– volume: 38
  start-page: e164
  year: 2010
  ident: 10.1111/jth.15630_bb0135
  article-title: ANNOVAR: functional annotation of genetic variants from high‐throughput sequencing data
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkq603
– volume: 51
  start-page: 1574
  year: 2019
  ident: 10.1111/jth.15630_bb0065
  article-title: Genome‐wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease
  publication-title: Nat Genet
  doi: 10.1038/s41588-019-0519-3
– volume: 33
  start-page: 1435
  year: 2013
  ident: 10.1111/jth.15630_bb0080
  article-title: Association of the thrombomodulin gene c.1418C>T polymorphism with thrombomodulin levels and with venous thrombosis risk
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.113.301360
– volume: 65
  start-page: 511
  year: 1991
  ident: 10.1111/jth.15630_bb0085
  article-title: A frequent thrombomodulin amino acid dimorphism is not associated with thrombophilia
  publication-title: Thromb Haemost
  doi: 10.1055/s-0038-1648181
– volume: 124
  start-page: 26S
  issue: 3 Suppl
  year: 2003
  ident: 10.1111/jth.15630_bb0015
  article-title: The protein C pathway
  publication-title: Chest
  doi: 10.1378/chest.124.3_suppl.26S
– volume: 42
  start-page: 135
  year: 2016
  ident: 10.1111/jth.15630_bb0095
  article-title: Thrombomodulin gene c.1418C>T polymorphism and risk of recurrent venous thromboembolism
  publication-title: J Thromb Thrombolysis
  doi: 10.1007/s11239-015-1328-x
– volume: 14
  issue: 5
  year: 2021
  ident: 10.1111/jth.15630_bb0115
  article-title: Regeneron Genetics Center. Thrombotic risk determined by STAB 2 Variants in a Population‐Based Cohort Study
  publication-title: Circ Genom Precis Med
  doi: 10.1161/CIRCGEN.121.003449
– volume: 124
  start-page: 663
  year: 2009
  ident: 10.1111/jth.15630_bb0150
  article-title: Prospective analysis of risk factors and distribution of venous thromboembolism in the population‐based Malmö Thrombophilia Study (MATS)
  publication-title: Thromb Res
  doi: 10.1016/j.thromres.2009.04.022
– volume: 101
  start-page: 1983
  year: 1998
  ident: 10.1111/jth.15630_bb0030
  article-title: A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state
  publication-title: J Clin Invest
  doi: 10.1172/JCI2006
– volume: 13
  start-page: 971
  year: 2020
  ident: 10.1111/jth.15630_bb0045
  article-title: Genetic risk factors for venous thromboembolism
  publication-title: Expert Rev Hematol
  doi: 10.1080/17474086.2020.1804354
– volume: 118
  start-page: 595
  year: 2002
  ident: 10.1111/jth.15630_bb0090
  article-title: Mutations in the thrombomodulin gene are rare in patients with severe thrombophilia
  publication-title: Br J Haematol
  doi: 10.1046/j.1365-2141.2002.03644.x
– volume: 119
  start-page: 35
  year: 2007
  ident: 10.1111/jth.15630_bb0100
  article-title: Haplotype of thrombomodulin gene associated with plasma thrombomodulin level and deep vein thrombosis in the Japanese population
  publication-title: Thromb Res
  doi: 10.1016/j.thromres.2005.12.012
– volume: 92
  start-page: 850
  year: 1995
  ident: 10.1111/jth.15630_bb0145
  article-title: Absence of the blood‐clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.92.3.850
SSID ssj0019520
Score 2.4897628
Snippet Background The protein C anticoagulant system plays a key role in maintaining the hemostatic balance. Although several studies have identified thrombomodulin...
The protein C anticoagulant system plays a key role in maintaining the hemostatic balance. Although several studies have identified thrombomodulin gene (THBD)...
BackgroundThe protein C anticoagulant system plays a key role in maintaining the hemostatic balance. Although several studies have identified thrombomodulin...
Background: The protein C anticoagulant system plays a key role in maintaining the hemostatic balance. Although several studies have identified thrombomodulin...
SourceID swepub
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 929
SubjectTerms Aged
Blood pressure
Body mass index
Cardiology and Cardiovascular Disease
Clinical Medicine
Cohort analysis
Cohort Studies
epidemiology
Female
Gene frequency
genetics
Humans
Kardiologi och kardiovaskulära sjukdomar
Klinisk medicin
Male
Medical and Health Sciences
Medicin och hälsovetenskap
Middle Aged
Population studies
Population-based studies
Principal components analysis
Protein C
Protein C - genetics
Risk Factors
THBD
Thromboembolism
Thrombomodulin
Thrombomodulin - genetics
Thrombosis
venous thromboembolism
Venous Thromboembolism - diagnosis
Venous Thromboembolism - epidemiology
Venous Thromboembolism - genetics
Title Thrombomodulin (THBD) gene variants and thrombotic risk in a population‐based cohort study
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjth.15630
https://www.ncbi.nlm.nih.gov/pubmed/34970867
https://www.proquest.com/docview/2640865991
https://www.proquest.com/docview/2615919215
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1538-7836
  dateEnd: 20240930
  omitProxy: true
  ssIdentifier: ssj0019520
  issn: 1538-7933
  databaseCode: DIK
  dateStart: 20030101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1538-7836
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0019520
  issn: 1538-7933
  databaseCode: AKRWK
  dateStart: 20030701
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 1538-7933
  databaseCode: DR2
  dateStart: 20030101
  customDbUrl:
  isFulltext: true
  eissn: 1538-7836
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0019520
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZpDqWXvh9u0qCWHtKDl7UlWRI99RWWQEopGwgloEqyhCGJvex6e8ipP6G_sb-kI_lBtk2h9GbweGTJM9I30vgbhF4SRwksnDaVTsuUmiJPpZc8zXwutGc06zbcjj4Ws2N6eMJOttDr4V-Yjh9i3HALnhHn6-Dg2qyuOnlbTbLAbgXzb0ZYPKL9PFJHZZJFSsbo0GCDpGcVilk8w5Oba9EfAHNkD90ErnHlObiDTod37hJOzibr1kzs5W90jv_Zqbvodo9I8ZvOhO6hLVffRzeP-jP3B-h0Xi2bC9NcNGXIWsf789nb968wGJ7D3yDSDok0WNclbjs5UINDwjoGWY0XY4Gwn99_hCWzxKEm77LFkdj2ITo--DB_N0v7mgypZTwcA5OM8bLwQjBXCsOsy12mC2tFad3UWi9tbo0stLcQ2RVCCkEK72UoXmgZTCGP0Hbd1O4JwpwQHZJMnaSeEmpBNiu1kS7zHHCRTdD-8HWU7QnLQ92MczUGLm2l4mgl6MUouuhYOq4T2h0-seoddaUAD0JQxwAlJ-j5eBtcLJyb6No16yADmC_wxrEEPe5MY2yFUMlBAU_Ql85WxjuBt7sLoVTP21Sp87VaObW4siGrWMmZMV4q67hX1HOrhLNTZVzhvCunhDB4ta_XKB-09o1UZ8ugXAfO5c0mSO6EpCaHjuRSgT9SgEhUKq61lga6BbgXBjva5d-HTx3OZ_Hi6b-L7qBbefhdJGY67aLtdrl2zwDEtWYP3cjpp73os78AGlFHow
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZKkYAL4s1CAYM4lEPQJrbjWOLCqwqlW3FIpQohubZjayXazWqb5cxP4DfyS5hxHuqKInFbKZPxxvYXf2NPviHkJfOcwcLpEuWNSrjNs0QFJZM0ZIUJgqfdhtvsMC-P-P6xON4ib4ZvYTp9iHHDDZER39cIcNyQvojydv46RXmrK-Qqz7MpzumMfxnPEJSIoowR0jALWa8rFPN4hls3V6O_KOaoH7pJXePas3eL3OxJI33bjfJtsuUXd8i1WX8sfpd8q-ar5sw2Z02NieV0tyrffXhFYW54-gOCYcx1oWZR07azAzcUc8op2Bq6HGt4_f75C1e1mmLZ3FVLo_bsPXK097F6XyZ92YTECYkntSwVss5DUQhfF1Y4n_nU5M4VtfNT54JymbMqN8FB8JUXqihYHoLC-oJOAMrvk-1Fs_APCZWMGcwD9YoHzrgD27Q2Vvk0SKAubkJ2h-7TrtcUx9IWp3qMLdq5jj09IS9G02UnpHGZ0c4wBrrH0rkGygZxlwAiOyHPx8uAAjzaMAvfrNEGaBlKu4kJedCN3dgK40qCAzkhX7vBHK-gtHYX5eheWmmuT9f63OvlhT1TLWoprA1KOy-D5kE6XXg31dbnPvh6ypiAv3ZyifPBa9_I_PsKnRuURd5sgmW-UNxm8CCZ0gAZDiyGKy2NMcrCYwE1hc6Oc_Df3af3qzL-ePT_ps_I9bKaHeiDT4efH5MbGX7dEROTdsh2u1r7J8C5Wvs0QusPMpAqLg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELZKkSoulH8CBQziUA5ZbWI7jsUJKKul0AqhrVShSq7t2IrUNlltsz1w4hF4Rp6EsfOjLhQJcYvkyTh2ZuJv7Mk3CL0klhJYOE0srBIx1VkaCyd4nLg0V47RpN1w29vPpgd095AdrqHX_b8wLT_EsOHmPSN8r72Dzwt32cmbcpR4dqtr6DrNILryiOjLwB2VCBY4GYNHgxGSjlYopPH0t64uRn8gzIE-dBW5hqVnsomO-oduM05ORstGj8y33_gc_3NUt9DNDpLiN60N3UZrtrqDNva6Q_e76GhWLuozXZ_VhU9bx9uz6dudVxgsz-ILCLV9Jg1WVYGbVg7UYJ-xjkFW4flQIezn9x9-zSywL8q7aHBgtr2HDibvZ--mcVeUITaM-3NgkjBeZC7PmS1yzYxNbaIyY_LC2LExTpjUaJEpZyC0y3KR5yRzTvjqhYbBN-Q-Wq_qyj5EmBOifJapFdRRQg3IJoXSwiaOAzAyEdru3440HWO5L5xxKofIpSllmK0IvRhE5y1Nx1VCW_0rlp2nnksAhBDVMYDJEXo-NIOP-YMTVdl66WUA9HniOBahB61pDL0QKjgo4BH62trK0OKJu9sYSnbETaU8XcpzK-eXdmQlKzjT2glpLHeSOm5kbs1YaptZZ4sxIQwe7fgK5b3WrpPyZOGVK0-6vNoFSW0uqE5hIKmQ4JAUMBIVkiulhIZhAfCFyQ52-ffpk7uzabh49O-iz9DG552J_PRh_-NjdCP1v46ErKcttN4slvYJALpGPw2O-wuXV0mX
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Thrombomodulin+%28THBD%29+gene+variants+and+thrombotic+risk+in+a+population-based+cohort+study&rft.jtitle=Journal+of+thrombosis+and+haemostasis&rft.au=Manderstedt%2C+Eric&rft.au=Halld%C3%A9n%2C+Christer&rft.au=Lind-Halld%C3%A9n%2C+Christina&rft.au=Elf%2C+Johan&rft.date=2022-04-01&rft.issn=1538-7836&rft.eissn=1538-7836&rft.volume=20&rft.issue=4&rft.spage=929&rft_id=info:doi/10.1111%2Fjth.15630&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1538-7933&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1538-7933&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1538-7933&client=summon